Affimed
AFMD
AFMD was delisted on the 19th of May, 2025.
35 hedge funds and large institutions have $37.6M invested in Affimed in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 11 closing their positions.
7% more capital invested
Capital invested by funds: $35.3M → $37.6M (+$2.31M)
15% less funds holding
Funds holding: 41 → 35 (-6)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $61K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Muhlenkamp & Co
Wexford,
Pennsylvania
|
+$123K |
| 2 |
Morgan Stanley
New York
|
+$115K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$95K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$85.7K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$72.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$1.12M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$463K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$155K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$142K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$131K |
AFMD Hedge Fund Activity: Q3 2016 in Review
35 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Affimed (AFMD) for Q3 2016, worth a combined $37.6M — up 6.5% from $35.3M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of AFMD and 5 opened new positions — a net loss of 6 holders — while 12 trimmed existing stakes and 10 added.
The largest buyer was Muhlenkamp & Co, adding an estimated $123K. The largest seller was OrbiMed, cutting an estimated $1.12M.
- 35 institutional investors held Affimed (AFMD) as of Q3 2016, down from 41 in Q2 2016.
- Funds reported $37.6M of Affimed stock for Q3 2016, up 6.5% quarter-over-quarter.
- 5 funds opened new Affimed positions in Q3 2016 and 11 closed out, a net change of -6 holders.
- The largest Affimed buyer in Q3 2016 was Muhlenkamp & Co, an estimated $123K added.
- The largest Affimed seller in Q3 2016 was OrbiMed, an estimated $1.12M sold.
Based on aggregated 13F filings for Q3 2016.